Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
EBIT Growth

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) 93.14298.54-62.910.46-30.07

What is the latest EBIT Growth ratio of NATCO PHARMA ?

The latest EBIT Growth ratio of NATCO PHARMA is 93.14 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar202493.14
Mar2023298.54
Mar2022-62.91
Mar20210.46
Mar2020-30.07

How is EBIT Growth of NATCO PHARMA Trending?

Years EBIT Growth % Change
Mar2024 93.14
-68.80
Mar2023 298.54
Positive
Mar2022 -62.91
Negative
Mar2021 0.46
Positive
Mar2020 -30.07 -

Other Financial Ratios of NATCO PHARMA


Compare EBIT Growth ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹22,268.4 Cr 1.9% -12.4% 53.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,715.0 Cr 0.3% -2.6% 36.7% Stock Analytics
DIVIS LABORATORIES ₹154,460.0 Cr -1% -0.5% 60.8% Stock Analytics
CIPLA ₹115,271.0 Cr -1.4% -3.1% 11.8% Stock Analytics
DR REDDYS LABORATORIES ₹107,511.0 Cr -3.8% -4% 15.3% Stock Analytics
ZYDUS LIFESCIENCES ₹99,189.5 Cr 0.1% 1.2% 40.3% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

1.9%

-12.4%

53.7%

SENSEX

-0.9%

-4.3%

3.7%


You may also like the below Video Courses